[Dysfunction in a Hancock mitral valve bioprosthesis caused by thrombosis and resolved with heparin].
Thrombotic malfunction is a rare and shortly documented complication of cardiac bioprostheses. Surgical treatment is usually needed. We report a patient with thrombotic occlusion of a Hancock mitral prosthesis which was resolved with heparin. Clinical and therapeutic features are discussed. To our knowledge, this is the first case of a bioprosthetic thrombotic obstruction successfully managed with heparin therapy.
Moujir
F
F
Martín-Durán
R
R
Vázquez de Prada
J A
JA
Trugeda
A
A
Figueroa
A
A
Olalla
J J
JJ
D001705:Bioprosthesis / Q000009:adverse effects*; D004452:Echocardiography; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000601:surgery; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*
D006493:Heparin
Disfunción por trombosis en bioprótesis de Hancock mitral resuelta con heparina.